News
You have been exercising, eating home-cooked meals, and have managed to cut out fried food and desserts from your diet for ...
Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...
The B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...
National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient models from Eli Lilly and Novo Nordisk.
Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
The foundation behind Novo Nordisk, which makes weight-loss drugs Ozempic and Wegovy, will invest €80 million ($93 million) ...
Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results